This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2003
Title: Annie Ooms - Innovator in Peptide Technology
Introduction
Annie Ooms is a notable inventor based in Liége, Belgium. She has made significant contributions to the field of peptide technology, particularly in the development of isolated peptides that have important applications in immunology.
Latest Patents
Annie Ooms holds a patent for "Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof." This invention relates to peptides that bind to HLA-B35 molecules, facilitating recognition and lysis of the resulting complexes by cytolytic T cells. Additionally, her patent includes nucleic acid molecules that encode these peptides, with some derived from tyrosinase, as well as portions of the tyrosinase molecule and the corresponding nucleic acid molecules.
Career Highlights
Throughout her career, Annie Ooms has demonstrated a strong commitment to advancing scientific knowledge and innovation in her field. Her work has the potential to impact therapeutic strategies in immunology and cancer treatment.
Collaborations
Annie has collaborated with esteemed colleagues such as Gérard De Giiovanni and Sandra Morel, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Annie Ooms is a pioneering inventor whose work in peptide technology is paving the way for new advancements in immunology. Her contributions are significant and reflect her dedication to scientific progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile